Bilcare has been associated with Biocon to provide secure, non-clonable track and trace technology for protection of Biocon’s exports across globe. Bilcare is providing end-to-end holistic solutions to Biocon for track and trace and authentication as per global standards. Bilcare will also build the ability to scale the service requirements to accommodate future needs.
This association will bring multi-level benefits to Biocon including capability to deal with on-going changes in government mandates, reduced spend on IT assets and services, handle high volume (billions of records) serialised data and its retention and allowing the company to manage any country-specific additional data requirements.
Biocon is a key client as it helps reinforce Bilcare’s capabilities to provide value to pharmaceutical industry. Bilcare is confident that the synergy will go a long way with the organisation providing best available solutions to Biocon. With well-equipped nonclonable track and trace technology, the company ascertains that the protection of the export products meets the government standards for export.
Bilcare’s nonClonable track and trace solution is secure, cost effective which facilitated Biocon to protect it exports brands and comply with Government’s DGFT mandate without hampering current productivity. This technology provides secure track and trace along with nonClonableID making it impossible for counterfeiters to copy. Conventional track and trace solution provide traceability but cannot provide protection from counterfeit which is the key motive to implement the mandate.
Bilcare Technologies’ secure track and trace and authentication solution can authenticate combined with track and trace, manage billions of records of serialised data and retain as per GS1/EPCIS, standardise data exchange with port authorities and importers for international trade, and enable accountability along with integration & outcomes to all stakeholders.
EP News Bureau – Mumbai